IN2014MN02391A - - Google Patents
Info
- Publication number
- IN2014MN02391A IN2014MN02391A IN2391MUN2014A IN2014MN02391A IN 2014MN02391 A IN2014MN02391 A IN 2014MN02391A IN 2391MUN2014 A IN2391MUN2014 A IN 2391MUN2014A IN 2014MN02391 A IN2014MN02391 A IN 2014MN02391A
- Authority
- IN
- India
- Prior art keywords
- reduced form
- chalcogenides
- compositions
- methods
- chalcogenide
- Prior art date
Links
- 150000004770 chalcogenides Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
- C01B17/22—Alkali metal sulfides or polysulfides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
- C01B17/22—Alkali metal sulfides or polysulfides
- C01B17/24—Preparation by reduction
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
- C01B17/22—Alkali metal sulfides or polysulfides
- C01B17/32—Hydrosulfides of sodium or potassium
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B19/00—Selenium; Tellurium; Compounds thereof
- C01B19/007—Tellurides or selenides of metals
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B19/00—Selenium; Tellurium; Compounds thereof
- C01B19/04—Binary compounds including binary selenium-tellurium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/08—Tubes; Storage means specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659311P | 2012-06-13 | 2012-06-13 | |
| US201361798043P | 2013-03-15 | 2013-03-15 | |
| PCT/US2013/045395 WO2013188528A1 (en) | 2012-06-13 | 2013-06-12 | Compositions comprising chalcogenides and related methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02391A true IN2014MN02391A (enExample) | 2015-08-21 |
Family
ID=49758688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2391MUN2014 IN2014MN02391A (enExample) | 2012-06-13 | 2013-06-12 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150290240A1 (enExample) |
| EP (1) | EP2861718A4 (enExample) |
| JP (1) | JP2015527975A (enExample) |
| KR (1) | KR20150021509A (enExample) |
| CN (1) | CN104471058A (enExample) |
| AU (1) | AU2013274325A1 (enExample) |
| BR (1) | BR112014030992A2 (enExample) |
| CA (1) | CA2875212A1 (enExample) |
| HK (1) | HK1209782A1 (enExample) |
| IN (1) | IN2014MN02391A (enExample) |
| MX (1) | MX2014014524A (enExample) |
| RU (1) | RU2015100257A (enExample) |
| WO (1) | WO2013188528A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX386702B (es) * | 2014-02-10 | 2025-03-19 | Fred Hutchinson Cancer Center | Tratamiento con halogeno de ataque cardiaco y lesion isquemica. |
| CN109650353A (zh) * | 2019-01-14 | 2019-04-19 | 成都中建材光电材料有限公司 | 一种高纯二硫化硒的制备方法 |
| US20230256003A1 (en) * | 2020-06-25 | 2023-08-17 | Industry-University Cooperation Foundation Hanyang University Erica Campus | Pharmaceutical composition for preventing or treating sepsis containing functionalized transition metal dichalcogenide |
| CN114471430B (zh) * | 2022-02-07 | 2024-01-02 | 天津大学 | 一种连续生产碱金属硫化物的装置及其合成方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1499852A (en) * | 1975-03-04 | 1978-02-01 | Smith & Nephew Pharma | Packaging |
| US5208336A (en) * | 1990-10-19 | 1993-05-04 | Sterling Drug Inc. | Selenomerocyanines and processes for preparation and methods of use and compositions thereof |
| US5616214A (en) * | 1995-09-12 | 1997-04-01 | Pulp And Paper Research Institute Of Canada | Determination of sodium sulfide and sulfidity in green liquors and smelt solutions |
| PE20001435A1 (es) * | 1998-11-16 | 2000-12-14 | Paques Bio Syst Bv | Proceso para la produccion de sulfuro de hidrogeno a partir de azufre en su condicion elemental y uso del mismo en la recuperacion de metales pesados |
| US6579705B2 (en) * | 2001-04-04 | 2003-06-17 | Consortium Fur Elektrochemische Industrie Gmbh | Process for preparing non-proteinogenic L-amino acids |
| EP1479725B1 (en) * | 2002-02-26 | 2014-05-14 | Kuraray Co., Ltd. | Resin composition and multi-layer structures |
| EP1753428A4 (en) * | 2004-05-14 | 2010-09-15 | Abbott Lab | INHIBITORS OF KINASES AS THERAPEUTIC AGENTS |
| WO2007124447A2 (en) * | 2006-04-20 | 2007-11-01 | Fred Hutchinson Cancer Research Center | Use of chalcogenides for treating shock and other adverse conditions |
| JP5303465B2 (ja) * | 2006-10-05 | 2013-10-02 | イカリア， インコーポレイテッド | 液体カルコゲナイド組成物ならびにそれを製造および使用する方法 |
| JP5083753B2 (ja) * | 2007-02-26 | 2012-11-28 | 独立行政法人理化学研究所 | ４，５−ジメチル−［１，３］ジセレノール−２−セロンの新規製造方法 |
| JP4028588B2 (ja) * | 2007-04-27 | 2007-12-26 | 政弘 井筒 | リグノセルロース系バイオマスの利用方法 |
| RU2015109165A (ru) * | 2008-03-06 | 2015-11-10 | Анакор Фармасьютикалз, Инк. | Борсодержащие малые молекулы в качестве противовоспалительных агентов |
-
2013
- 2013-06-12 CN CN201380031213.4A patent/CN104471058A/zh active Pending
- 2013-06-12 IN IN2391MUN2014 patent/IN2014MN02391A/en unknown
- 2013-06-12 KR KR20147033920A patent/KR20150021509A/ko not_active Withdrawn
- 2013-06-12 CA CA2875212A patent/CA2875212A1/en not_active Abandoned
- 2013-06-12 BR BR112014030992A patent/BR112014030992A2/pt not_active IP Right Cessation
- 2013-06-12 RU RU2015100257A patent/RU2015100257A/ru not_active Application Discontinuation
- 2013-06-12 JP JP2015517392A patent/JP2015527975A/ja active Pending
- 2013-06-12 WO PCT/US2013/045395 patent/WO2013188528A1/en not_active Ceased
- 2013-06-12 EP EP13805096.8A patent/EP2861718A4/en not_active Withdrawn
- 2013-06-12 AU AU2013274325A patent/AU2013274325A1/en not_active Abandoned
- 2013-06-12 US US14/406,859 patent/US20150290240A1/en not_active Abandoned
- 2013-06-12 MX MX2014014524A patent/MX2014014524A/es unknown
- 2013-06-12 HK HK15110369.5A patent/HK1209782A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20150290240A1 (en) | 2015-10-15 |
| WO2013188528A1 (en) | 2013-12-19 |
| AU2013274325A1 (en) | 2014-12-11 |
| MX2014014524A (es) | 2015-02-24 |
| EP2861718A4 (en) | 2016-03-23 |
| JP2015527975A (ja) | 2015-09-24 |
| RU2015100257A (ru) | 2016-08-10 |
| CN104471058A (zh) | 2015-03-25 |
| CA2875212A1 (en) | 2013-12-19 |
| BR112014030992A2 (pt) | 2017-06-27 |
| KR20150021509A (ko) | 2015-03-02 |
| EP2861718A1 (en) | 2015-04-22 |
| HK1209782A1 (en) | 2016-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180102A1 (ar) | مركب صيدلاني | |
| GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
| IL244677B (en) | Effective preparations for the treatment of kit-related disorders | |
| MD20150091A2 (ro) | Compuşi antivirali | |
| PH12014502757B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| MX2015008187A (es) | Inhibidores de alk deuterados. | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| MX2013000793A (es) | Composicion que contiene galacto-oligosacarido y un metodo para producirla. | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
| PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
| IL239535A0 (en) | The compositions for whitening with controlled release | |
| PH12015502747A1 (en) | Novel compounds for the treatment of cancer | |
| IN2015DN00833A (enExample) | ||
| EP2794806A4 (en) | AZEOTROPÄHNLICHE COMPOSITIONS WITH CIS-1-CHLORO-3,3,3-TRIFLUORPROPEN | |
| IL237483A0 (en) | Preparations for the treatment of psoriasis | |
| CL2014001471A1 (es) | Composiciones anhidro antitranspirantes; metodo para reducir transpiracion; y metodo de fabricación de dicha composicion. | |
| IN2014MN02391A (enExample) | ||
| EA201491581A1 (ru) | Везикулярные композиции | |
| IN2014DN03245A (enExample) | ||
| EP2651429A4 (en) | NEUROPEPTIDE ANALOGUES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN | |
| WO2012158493A3 (en) | Compounds that bind to the erythropoietin receptor | |
| EA201591449A1 (ru) | Способы получения противораковых композиций | |
| MX2015007460A (es) | Agentes para el tratamiento del dolor y usos de los mismos. | |
| PH12015502703A1 (en) | Pharmaceutical compositions |